1. Home
  2. CORT vs GSAT Comparison

CORT vs GSAT Comparison

Compare CORT & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

SELL

Current Price

$113.79

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Logo Globalstar Inc.

GSAT

Globalstar Inc.

HOLD

Current Price

$82.98

Market Cap

10.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
GSAT
Founded
1998
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.7B
IPO Year
2001
2006

Fundamental Metrics

Financial Performance
Metric
CORT
GSAT
Price
$113.79
$82.98
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$96.50
$70.50
AVG Volume (30 Days)
823.3K
538.0K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
74.58
EPS
0.09
N/A
Revenue
$761,407,000.00
$112,660,000.00
Revenue This Year
$26.08
$10.31
Revenue Next Year
$26.98
$15.93
P/E Ratio
$1,224.56
N/A
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$33.90
52 Week High
$126.38
$84.85

Technical Indicators

Market Signals
Indicator
CORT
GSAT
Relative Strength Index (RSI) 52.88 60.13
Support Level $108.25 $80.90
Resistance Level $124.30 $84.77
Average True Range (ATR) 5.29 0.56
MACD -0.76 0.08
Stochastic Oscillator 61.04 93.47

Price Performance

Historical Comparison
CORT
GSAT

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: